LA JOLLA PHARMACEUTICAL CO (LJPC) [Rocket]

In millions, except per share items	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21	Dec-31-20	Sep-30-20
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Net income	2.5	0.0	3.8	-2.3	3.7	14.4	-3.5	-11.8
Depreciation and amortization [+]	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
Amortization of intangible assets	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3
Asset impairment charges						0.9	1.3	1.2
Stock-based compensation	1.4	1.3	1.2	1.2	1.0	1.1	0.8	1.4
Change in working capital [+]	0.7	2.2	-5.6	-0.5	-2.8	-1.8	-5.9	-2.6
Accounts receivable	-0.2	2.9	0.2	-0.2	-4.4	1.7	-1.9	-0.9
Inventories	-1.2	-0.8	-0.2	-0.6	-0.1	-0.2	0.0	-0.6
Other current assets	1.7	0.2	-1.5	0.9	0.9	-2.7	-0.1	0.8
Accrued expenses	1.1	-0.6	-4.8	-0.9	0.1	1.1	-5.6	-2.4
Other	-0.7	0.5	0.8	0.4	0.7	-1.7	1.8	0.5
Other operating activities	1.8	-1.4	3.4	1.9	4.8	2.2	-0.4	1.4
Cash from operations	6.7	2.5	3.2	0.8	7.1	17.2	-7.3	-9.8

Capital expenditures [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Purchases of property and equipment				0.0
Sales of property and equipment								0.2
Sales of short-term investments								2.5
Sales of short-term investments								2.5
Other cash from investing	0.3							-33.5
Cash from investing	0.3	0.0	0.0	0.0	0.0	0.0	0.0	-30.8

Repurchase of common stock, net	-2.9	-5.2	-3.4	0.0	0.0	0.2
Other cash from financing	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
Cash from financing	-2.8	-5.0	-3.3	0.1	0.1	0.2	0.1	0.1

Free cash flow	6.7	2.5	3.2	0.8	7.1	17.2	-7.3	-9.8
Per share (diluted)	$0.21	$0.08	$0.09	$0.03	$0.21	$0.50	($0.27)	($0.36)